Vitamin E and donepezil for the treatment of mild cognitive impairment - PubMed

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Sep 1;353(9):951-2; author reply 951-2.

doi: 10.1056/NEJMc051856.

Vitamin E and donepezil for the treatment of mild cognitive impairment

Deborah E Barnes, Kristine Yaffe

PMID: 16135844
DOI: 10.1056/NEJMc051856

Comment

Vitamin E and donepezil for the treatment of mild cognitive impairment

Deborah E Barnes et al. N Engl J Med. 2005.

. 2005 Sep 1;353(9):951-2; author reply 951-2.

doi: 10.1056/NEJMc051856.

Authors

Deborah E Barnes, Kristine Yaffe

PMID: 16135844
DOI: 10.1056/NEJMc051856

No abstract available

PubMed Disclaimer

Comment on

Vitamin E and donepezil for the treatment of mild cognitive impairment.
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group. Petersen RC, et al. N Engl J Med. 2005 Jun 9;352(23):2379-88. doi: 10.1056/NEJMoa050151. Epub 2005 Apr 13. N Engl J Med. 2005. PMID: 15829527 Clinical Trial.

Similar articles

Mild cognitive impairment--no benefit from vitamin E, little from donepezil.
Blacker D. Blacker D. N Engl J Med. 2005 Jun 9;352(23):2439-41. doi: 10.1056/NEJMe058086. Epub 2005 Apr 13. N Engl J Med. 2005. PMID: 15829528 No abstract available.
Vitamin E and donepezil for the treatment of mild cognitive impairment.
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group. Petersen RC, et al. N Engl J Med. 2005 Jun 9;352(23):2379-88. doi: 10.1056/NEJMoa050151. Epub 2005 Apr 13. N Engl J Med. 2005. PMID: 15829527 Clinical Trial.
Donepezil for severe Alzheimer's disease.
Allsop D, Martin FL, Moore S, Fullwood NJ; Alzheimer's Society. Allsop D, et al. Lancet. 2006 Jul 29;368(9533):361; author reply 362. doi: 10.1016/S0140-6736(06)69097-1. Lancet. 2006. PMID: 16876652 No abstract available.
Therapeutic standards in Alzheimer disease.
Doody RS. Doody RS. Alzheimer Dis Assoc Disord. 1999 Nov;13 Suppl 2:S20-6. Alzheimer Dis Assoc Disord. 1999. PMID: 10622675 Review.
[Mild Cognitive Impairment: potential therapeutics].
Allain H, Bentue-Ferrer D, Belliard S, Reymann JM, Djemaï M, Merienne M. Allain H, et al. Rev Neurol (Paris). 2002;158(10 Suppl):S35-40. Rev Neurol (Paris). 2002. PMID: 12529584 Review. French.

See all similar articles

Cited by

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Bjelakovic G, et al. Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD007176. doi: 10.1002/14651858.CD007176.pub2. Cochrane Database Syst Rev. 2012. PMID: 22419320 Free PMC article. Review.
Cholinesterase inhibitors for mild cognitive impairment.
Russ TC, Morling JR. Russ TC, et al. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009132. doi: 10.1002/14651858.CD009132.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972133 Free PMC article. Review.
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.
Guo J, Cheng J, North BJ, Wei W. Guo J, et al. Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):341-358. doi: 10.1016/j.bbcan.2017.07.001. Epub 2017 Jul 8. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28694093 Free PMC article. Review.
Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer's disease.
Taubes A, Nova P, Zalocusky KA, Kosti I, Bicak M, Zilberter MY, Hao Y, Yoon SY, Oskotsky T, Pineda S, Chen B, Jones EAA, Choudhary K, Grone B, Balestra ME, Chaudhry F, Paranjpe I, De Freitas J, Koutsodendris N, Chen N, Wang C, Chang W, An A, Glicksberg BS, Sirota M, Huang Y. Taubes A, et al. Nat Aging. 2021 Oct;1(10):932-947. doi: 10.1038/s43587-021-00122-7. Epub 2021 Oct 11. Nat Aging. 2021. PMID: 36172600 Free PMC article.
Neuroprotective effects of ZL006 in Aβ_1-42-treated neuronal cells.
Tao WY, Yu LJ, Jiang S, Cao X, Chen J, Bao XY, Li F, Xu Y, Zhu XL. Tao WY, et al. Neural Regen Res. 2020 Dec;15(12):2296-2305. doi: 10.4103/1673-5374.285006. Neural Regen Res. 2020. PMID: 32594052 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information